nach oben

Endocrine

Erschienen in:

01.12.2014 | Review

Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation

verfasst von: F. Tanriverdi, Z. Karaca, K. Unluhizarci, F. Kelestimur

Erschienen in: Endocrine | Ausgabe 3/2014

Einloggen, um Zugang zu erhalten

Abstract

Based on the literature data in the last two decades, growth hormone deficiency (GHD) in adults has been accepted as a clinical entity. Due to the presence of GH and IGF-I receptors throughout the body, the physiological effects of the GH-IGF-I axis are still under investigation. The effects of GH on skin, sleep, and coagulation parameters in adults have only been investigated in detail only in the recent years. In this review, our aim was to summarize the literature regarding the effects of GHD and GH replacement treatment on the skin, sleep, and coagulation parameters in adults.

R.C. Cuneo, F. Salomon, G.A. McGauley, P.H. Sonksen, The growth hormone deficiency syndrome in adults. Clin. Endocrinol. (Oxf.) 37, 387–397 (1992)

G. Amato, C. Carella, S. Fazio, G. La Montagna, A. Cittadini, D. Sabatini, C. Marciano-Mone, L. Sacca, A. Bellastella, Body composition, bone metabolism, and heart structure and function in growth hormone (GH)-deficient adults before and after GH replacement therapy at low doses. J. Clin. Endocrinol. Metab. 77, 1671–1676 (1993)PubMed

B.A. Bengtsson, S. Eden, L. Lonn, H. Kvist, A. Stokland, G. Lindstedt, I. Bosaeus, J. Tolli, L. Sjostrom, O.G. Isaksson, Treatment of adults with growth hormone (GH) deficiency with recombinant human GH. J. Clin. Endocrinol. Metab. 76, 309–317 (1993)PubMed

C. Gazzaruso, M. Gola, I. Karamouzis, R. Giubbini, A. Giustina, Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH—an update. J. Clin. Endocrinol. Metab. 99, 18–29 (2014)PubMed

M. Gola, S. Bonadonna, M. Doga, A. Giustina, Clinical review: growth hormone and cardiovascular risk factors. J. Clin. Endocrinol. Metab. 90, 1864–1870 (2005)PubMed

M. Gola, A. Giustina, Growth hormone deficiency and cardiovascular risk: do we need additional markers? Endocrine 42, 240–242 (2012)PubMed

L. Li, W. Ren, J. Li, J. Liu, L. Wang, X. Zheng, D. Liu, S. Li, R. Souvenir, J. Tang, Increase in serum pregnancy-associated plasma protein-A is correlated with increase in cardiovascular risk factors in adult patients with growth hormone deficiency. Endocrine 42, 375–381 (2012)PubMed

H. de Boer, G.J. Blok, H.J. Voerman, M. Phillips, J.A. Schouten, Serum lipid levels in growth hormone-deficient men. Metabolism 43, 199–203 (1994)PubMed

F. Tanriverdi, K. Unluhizarci, M. Kula, M. Guven, F. Bayram, F. Kelestimur, Effects of 18-month of growth hormone (GH) replacement therapy in patients with Sheehan’s syndrome. Growth Horm. IGF Res. 15, 231–237 (2005)PubMed

10.

F. Tanriverdi, N.K. Eryol, H. Atmaca, K. Unluhizarci, I. Ozdogru, I. Sarikaya, F. Bayram, F. Kelestimur, The effects of 12 months of growth hormone replacement therapy on cardiac autonomic tone in adults with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 62, 706–712 (2005)

11.

V. Ekbote, A. Khadilkar, S. Chiplonkar, Z. Mughal, V. Khadilkar, Enhanced effect of zinc and calcium supplementation on bone status in growth hormone-deficient children treated with growth hormone: a pilot randomized controlled trial. Endocrine 43, 686–695 (2013)PubMed

12.

A. Giustina, G. Mazziotti, E. Canalis, Growth hormone, insulin-like growth factors, and the skeleton. Endocr. Rev. 29, 535–559 (2008)PubMedCentralPubMed

13.

G. Mazziotti, A. Bianchi, S. Bonadonna, M. Nuzzo, V. Cimino, A. Fusco, L. De Marinis, A. Giustina, Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy. J. Bone Miner. Res. 21, 520–528 (2006)PubMed

14.

F. Prodam, G. Aimaretti, Could zinc supplementation improve bone status in growth hormone (GH) deficient children? Endocrine 43, 467–468 (2013)PubMed

15.

J. Gibney, J.D. Wallace, T. Spinks, L. Schnorr, A. Ranicar, R.C. Cuneo, S. Lockhart, K.G. Burnand, F. Salomon, P.H. Sonksen, D. Russell-Jones, The effects of 10 years of recombinant human growth hormone (GH) in adult GH-deficient patients. J. Clin. Endocrinol. Metab. 84, 2596–2602 (1999)PubMed

16.

A. Slominski, J. Wortsman, Neuroendocrinology of the skin. Endocr. Rev. 21, 457–487 (2000)PubMed

17.

F. Kelestimur, Sheehan’s syndrome. Pituitary 6, 181–188 (2003)PubMed

18.

H.L. Sheehan, Postpartum necrosis of the anterior pituitary. J. Pathol. 45, 189–214 (1937)

19.

H.J. Schneider, G. Aimaretti, I. Kreitschmann-Andermahr, G.K. Stalla, E. Ghigo, Hypopituitarism. Lancet 369, 1461–1470 (2007)PubMed

20.

F. Tanriverdi, A. De Bellis, H. Ulutabanca, A. Bizzarro, A.A. Sinisi, G. Bellastella, P.V. Amoresano, M.L. Dalla, A. Selcuklu, K. Unluhizarci, F.F. Casanueva, F. Kelestimur, A five year prospective investigation of anterior pituitary function after traumatic brain injury: is hypopituitarism long-term after head trauma associated with autoimmunity? J. Neurotrauma 30, 1426–1433 (2013)PubMed

21.

P.E. Lobie, W. Breipohl, D.T. Lincoln, J. Garcia-Aragon, M.J. Waters, Localization of the growth hormone receptor/binding protein in skin. J. Endocrinol. 126, 467–471 (1990)PubMed

22.

S.R. Oakes, K.M. Haynes, M.J. Waters, A.C. Herington, G.A. Werther, Demonstration and localization of growth hormone receptor in human skin and skin fibroblasts. J. Clin. Endocrinol. Metab. 75, 1368–1373 (1992)PubMed

23.

J.A. Batch, F.A. Mercuri, S.R. Edmondson, G.A. Werther, Localization of messenger ribonucleic acid for insulin-like growth factor-binding proteins in human skin by in situ hybridization. J. Clin. Endocrinol. Metab. 79, 1444–1449 (1994)PubMed

24.

A. Tavakkol, J.T. Elder, C.E. Griffiths, K.D. Cooper, H. Talwar, G.J. Fisher, K.M. Keane, S.K. Foltin, J.J. Voorhees, Expression of growth hormone receptor, insulin-like growth factor 1 (IGF-1) and IGF-1 receptor mRNA and proteins in human skin. J. Invest. Dermatol. 99, 343–349 (1992)PubMed

25.

M. Borlu, Z. Karaca, H. Yildiz, F. Tanriverdi, B. Demirel, G. Elbuken, I. Cakir, H.S. Dokmetas, R. Colak, K. Unluhizarci, F. Kelestimur, Acromegaly is associated with decreased skin transepidermal water loss and temperature, and increased skin pH and sebum secretion partially reversible after treatment. Growth Horm. IGF Res. 22, 82–86 (2012)PubMed

26.

A. Jadresic, L.M. Banks, D.F. Child, L. Diamant, F.H. Doyle, T.R. Fraser, G.F. Joplin, The acromegaly syndrome. Relation between clinical features, growth hormone values and radiological characteristics of the pituitary tumours. Q. J. Med. 51, 189–204 (1982)PubMed

27.

J.D. Nabarro, Acromegaly. Clin. Endocrinol. (Oxf.) 26, 481–512 (1987)

28.

P.V. Carroll, E.R. Christ, B.A. Bengtsson, L. Carlsson, J.S. Christiansen, D. Clemmons, R. Hintz, K. Ho, Z. Laron, P. Sizonenko, P.H. Sonksen, T. Tanaka, M. Thorne, Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Growth Hormone Research Society Scientific Committee. J. Clin. Endocrinol. Metab. 83, 382–395 (1998)PubMed

29.

S.A. Pedersen, K. Welling, K.F. Michaelsen, J.O. Jorgensen, J.S. Christiansen, N.E. Skakkebaek, Reduced sweating in adults with growth hormone deficiency. Lancet 2, 681–682 (1989)PubMed

30.

K. Main, K.O. Nilsson, N.E. Skakkebaek, Influence of sex and growth hormone deficiency on sweating. Scand. J. Clin. Lab. Invest. 51, 475–480 (1991)PubMed

31.

K.M. Main, D.A. Price, M.O. Savage, N.E. Skakkebae, Decreased sweating in seven patients with Laron syndrome. J. Clin. Endocrinol. Metab. 77, 821–823 (1993)PubMed

32.

A. Juul, A. Behrenscheer, T. Tims, B. Nielsen, J. Halkjaer-Kristensen, N.E. Skakkebaek, Impaired thermoregulation in adults with growth hormone deficiency during heat exposure and exercise. Clin. Endocrinol. (Oxf.) 38, 237–244 (1993)

33.

A. Juul, N. Hjortskov, L.T. Jepsen, B. Nielsen, J. Halkjaer-Kristensen, N. Vahl, J.O. Jorgensen, J.S. Christiansen, N.E. Skakkebaek, Growth hormone deficiency and hyperthermia during exercise: a controlled study of sixteen GH-deficient patients. J. Clin. Endocrinol. Metab. 80, 3335–3340 (1995)PubMed

34.

J.C. Ives, M. Alderman, S.E. Stred, Hypopituitarism after multiple concussions: a retrospective case study in an adolescent male. J. Athl. Train. 42, 431–439 (2007)PubMedCentralPubMed

35.

F. Tanriverdi, K. Unluhizarci, B. Coksevim, A. Selcuklu, F.F. Casanueva, F. Kelestimur, Kickboxing sport as a new cause of traumatic brain injury-mediated hypopituitarism. Clin. Endocrinol. (Oxf.) 66, 360–366 (2007)

36.

F. Tanriverdi, K. Unluhizarci, I. Kocyigit, I.S. Tuna, Z. Karaca, A.C. Durak, A. Selcuklu, F.F. Casanueva, F. Kelestimur, Brief communication: pituitary volume and function in competing and retired male boxers. Ann. Intern. Med. 148, 827–831 (2008)PubMed

37.

S.B. Sneppen, K.M. Main, A. Juul, L.M. Pedersen, L.O. Kristensen, N.E. Skakkebaek, U. Feldt-Rasmussen, Sweat secretion rates in growth hormone disorders. Clin. Endocrinol. (Oxf.) 53, 601–608 (2000)

38.

R. Choudhry, M.B. Hodgins, T.H. Van der Kwast, A.O. Brinkmann, W.J. Boersma, Localization of androgen receptors in human skin by immunohistochemistry: implications for the hormonal regulation of hair growth, sebaceous glands and sweat glands. J. Endocrinol. 133, 467–475 (1992)PubMed

39.

K. Sato, W.H. Kang, K. Saga, K.T. Sato, Biology of sweat glands and their disorders. I. Normal sweat gland function. J. Am. Acad. Dermatol. 20, 537–563 (1989)PubMed

40.

J.M. Lundberg, B. Hedlund, T. Bartfai, Vasoactive intestinal polypeptide enhances muscarinic ligand binding in cat submandibular salivary gland. Nature 295, 147–149 (1982)PubMed

41.

W. Hasan, T. Cowen, P.S. Barnett, E. Elliot, P. Coskeran, P.M. Bouloux, The sweating apparatus in growth hormone deficiency, following treatment with r-hGH and in acromegaly. Auton. Neurosci. 89, 100–109 (2001)PubMed

42.

M. Lange, J. Thulesen, U. Feldt-Rasmussen, N.E. Skakkebaek, N. Vahl, J.O. Jorgensen, J.S. Christiansen, S.S. Poulsen, S.B. Sneppen, A. Juul, Skin morphological changes in growth hormone deficiency and acromegaly. Eur. J. Endocrinol. 145, 147–153 (2001)PubMed

43.

D. Deplewski, R.L. Rosenfield, Role of hormones in pilosebaceous unit development. Endocr. Rev. 21, 363–392 (2000)PubMed

44.

F. Kelestimur, GH deficiency and the degree of hypopituitarism. Clin. Endocrinol. (Oxf.) 42, 443–444 (1995)

45.

M. Borlu, F. Tanriverdi, C.A. Koc, K. Unluhizarci, S. Utas, F. Kelestimur, The effects of severe growth hormone deficiency on the skin of patients with Sheehan’s syndrome. J. Eur. Acad. Dermatol. Venereol. 21, 199–204 (2007)PubMed

46.

F. Tanriverdi, M. Borlu, H. Atmaca, C.A. Koc, K. Unluhizarci, S. Utas, F. Kelestimur, Investigation of the skin characteristics in patients with severe GH deficiency and the effects of 6 months of GH replacement therapy: a randomized placebo controlled study. Clin. Endocrinol. (Oxf.) 65, 579–585 (2006)

47.

D. Deplewski, R.L. Rosenfield, Growth hormone and insulin-like growth factors have different effects on sebaceous cell growth and differentiation. Endocrinology 140, 4089–4094 (1999)PubMed

48.

A.R. Buz’Zard, Q. Peng, B.H. Lau, Kyolic and Pycnogenol increase human growth hormone secretion in genetically-engineered keratinocytes. Growth Horm. IGF Res. 12, 34–40 (2002)PubMed

49.

G. Broniarczyk-Dyla, E. Joss-Wichman, Ageing of the skin during menopause. J. Eur. Acad. Dermatol. Venereol. 15, 494–495 (2001)PubMed

50.

D.R. Clemmons, M. Molitch, A.R. Hoffman, A. Klibanski, C.J. Strasburger, D.L. Kleinberg, K. Ho, S.M. Webb, M.D. Bronstein, R. Bouillon, A. Ben Shlomo, A.H. Hamrahian, P. Chanson, A.L. Barkan, G.R. Merriam, M.R. Blackman, R. Salvatori, Growth hormone should be used only for approved indications. J. Clin. Endocrinol. Metab. 99, 409–411 (2014)PubMed

51.

S.R. Edmondson, S.P. Thumiger, G.A. Werther, C.J. Wraight, Epidermal homeostasis: the role of the growth hormone and insulin-like growth factor systems. Endocr. Rev. 24, 737–764 (2003)PubMed

52.

A. Steiger, Sleep, endocrinology. J. Intern. Med. 254, 13–22 (2003)PubMed

53.

E. Van Cauter, L. Plat, G. Copinschi, Interrelations between sleep and the somatotropic axis. Sleep 21, 553–566 (1998)PubMed

54.

C. Gronfier, G. Brandenberger, Ultradian rhythms in pituitary and adrenal hormones: their relations to sleep. Sleep Med. Rev. 2, 17–29 (1998)PubMed

55.

K. Spiegel, R. Leproult, E.F. Colecchia, M. L’Hermite-Baleriaux, Z. Nie, G. Copinschi, E. Van Cauter, Adaptation of the 24-h growth hormone profile to a state of sleep debt. Am. J. Physiol. Regul. Integr. Comp. Physiol. 279, R874–R883 (2000)PubMed

56.

E. Van Cauter, A. Caufriez, M. Kerkhofs, A. Van Onderbergen, M.O. Thorner, G. Copinschi, Sleep, awakenings, and insulin-like growth factor-I modulate the growth hormone (GH) secretory response to GH-releasing hormone. J. Clin. Endocrinol. Metab. 74, 1451–1459 (1992)PubMed

57.

E.D. Weitzman, Biologic rhythms and hormone secretion patterns. Hosp. Pract. 11, 79–86 (1976)PubMed

58.

F. Obal Jr, R. Floyd, L. Kapas, B. Bodosi, J.M. Krueger, Effects of systemic GHRH on sleep in intact and hypophysectomized rats. Am. J. Physiol. 270, E230–E237 (1996)PubMed

59.

L. Marshall, M. Molle, G. Boschen, A. Steiger, H.L. Fehm, J. Born, Greater efficacy of episodic than continuous growth hormone-releasing hormone (GHRH) administration in promoting slow-wave sleep (SWS). J. Clin. Endocrinol. Metab. 81, 1009–1013 (1996)PubMed

60.

A. Steiger, J. Guldner, U. Hemmeter, B. Rothe, K. Wiedemann, F. Holsboer, Effects of growth hormone-releasing hormone and somatostatin on sleep EEG and nocturnal hormone secretion in male controls. Neuroendocrinology 56, 566–573 (1992)PubMed

61.

F. Obal Jr, P. Alfoldi, A.B. Cady, L. Johannsen, G. Sary, J.M. Krueger, Growth hormone-releasing factor enhances sleep in rats and rabbits. Am. J. Physiol. 255, R310–R316 (1988)PubMed

62.

J. Zhang, F. Obal Jr, T. Zheng, J. Fang, P. Taishi, J.M. Krueger, Intrapreoptic microinjection of GHRH or its antagonist alters sleep in rats. J. Neurosci. 19, 2187–2194 (1999)PubMed

63.

M. Kerkhofs, E. Van Cauter, A. Van Onderbergen, A. Caufriez, M.O. Thorner, G. Copinschi, Sleep-promoting effects of growth hormone-releasing hormone in normal men. Am. J. Physiol. 264, E594–E598 (1993)PubMed

64.

B. Perras, L. Marshall, G. Kohler, J. Born, H.L. Fehm, Sleep and endocrine changes after intranasal administration of growth hormone-releasing hormone in young and aged humans. Psychoneuroendocrinology 24, 743–757 (1999)PubMed

65.

S. Mathias, K. Held, M. Ising, J.C. Weikel, A. Yassouridis, A. Steiger, Systemic growth hormone-releasing hormone (GHRH) impairs sleep in healthy young women. Psychoneuroendocrinology 32, 1021–1027 (2007)PubMed

66.

G. Copinschi, A. Nedeltcheva, R. Leproult, L.L. Morselli, K. Spiegel, E. Martino, J.J. Legros, R.E. Weiss, J. Mockel, E. Van Cauter, Sleep disturbances, daytime sleepiness, and quality of life in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 95, 2195–2202 (2010)PubMedCentralPubMed

67.

J. Zhang, F. Obal Jr, J. Fang, B.J. Collins, J.M. Krueger, Non-rapid eye movement sleep is suppressed in transgenic mice with a deficiency in the somatotropic system. Neurosci. Lett. 220, 97–100 (1996)PubMed

68.

C. Astrom, Interaction between sleep and growth hormone. Evaluated by manual polysomnography and automatic power spectrum analysis. Acta Neurol. Scand. 92, 281–296 (1995)PubMed

69.

W.B. Mendelson, S. Slater, P. Gold, J.C. Gillin, The effect of growth hormone administration on human sleep: a dose-response study. Biol. Psychiatry 15, 613–618 (1980)PubMed

70.

C. Astrom, J. Lindholm, Growth hormone-deficient young adults have decreased deep sleep. Neuroendocrinology 51, 82–84 (1990)PubMed

71.

S. Ismailogullari, F. Tanriverdi, F. Kelestimur, M. Aksu, Sleep architecture in Sheehan’s syndrome before and 6 months after growth hormone replacement therapy. Psychoneuroendocrinology 34, 212–219 (2009)PubMed

72.

L.L. Morselli, A. Nedeltcheva, R. Leproult, K. Spiegel, E. Martino, J.J. Legros, R.E. Weiss, J. Mockel, E. Van Cauter, G. Copinschi, Impact of GH replacement therapy on sleep in adult patients with GH deficiency of pituitary origin. Eur. J. Endocrinol. 168, 763–770 (2013)PubMed

73.

W. Nolte, C. Radisch, A. Rodenbeck, J. Wiltfang, M. Hufner, Polysomnographic findings in five adult patients with pituitary insufficiency before and after cessation of human growth hormone replacement therapy. Clin. Endocrinol. (Oxf.) 56, 805–810 (2002)

74.

Y. Peker, J. Svensson, J. Hedner, L. Grote, G. Johannsson, Sleep apnoea and quality of life in growth hormone (GH)-deficient adults before and after 6 months of GH replacement therapy. Clin. Endocrinol. (Oxf.) 65, 98–105 (2006)

75.

H.J. Schneider, H. Oertel, H. Murck, T. Pollmacher, G.K. Stalla, A. Steiger, Night sleep EEG and daytime sleep propensity in adult hypopituitary patients with growth hormone deficiency before and after six months of growth hormone replacement. Psychoneuroendocrinology 30, 29–37 (2005)PubMed

76.

B. Bulow, L. Hagmar, Z. Mikoczy, C.H. Nordstrom, E.M. Erfurth, Increased cerebrovascular mortality in patients with hypopituitarism. Clin. Endocrinol. (Oxf.) 46, 75–81 (1997)

77.

B. Bulow, L. Hagmar, J. Eskilsson, E.M. Erfurth, Hypopituitary females have a high incidence of cardiovascular morbidity and an increased prevalence of cardiovascular risk factors. J. Clin. Endocrinol. Metab. 85, 574–584 (2000)PubMed

78.

E.M. Erfurth, B. Bulow, J. Eskilsson, L. Hagmar, High incidence of cardiovascular disease and increased prevalence of cardiovascular risk factors in women with hypopituitarism not receiving growth hormone treatment: preliminary results. Growth Horm. IGF Res. 9(Suppl A), 21–24 (1999)PubMed

79.

T. Rosen, B.A. Bengtsson, Premature mortality due to cardiovascular disease in hypopituitarism. Lancet 336, 285–288 (1990)PubMed

80.

A. Sartorio, M. Cattaneo, P. Bucciarelli, B. Bottasso, S. Porretti, P. Epaminonda, G. Faglia, M. Arosio, Alterations of haemostatic and fibrinolytic markers in adult patients with growth hormone deficiency and with acromegaly. Exp. Clin. Endocrinol. Diabetes 108, 486–492 (2000)PubMed

81.

J. Guevara-Aguirre, P. Balasubramanian, M. Guevara-Aguirre, M. Wei, F. Madia, C.W. Cheng, D. Hwang, A. Martin-Montalvo, J. Saavedra, S. Ingles, R. de Cabo, P. Cohen, V.D. Longo, Growth hormone receptor deficiency ıs associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans. Sci. Transl. Med. 16, 70ra13 (2011)

82.

M.H. Aguiar-Oliveira, F.T. Oliveira, R.M. Pereira, C.R. Oliveira, A. Blackford, E.H. Valenca, E.G. Santos, M.B. Gois-Junior, R.A. Meneguz-Moreno, V.P. Araujo, L.A. Oliveira-Neto, T.F. Lopes, E.O. Rodrigues, L.A. Porto, I.P. Oliveira, E.V. Melo, M. Martari, R. Salvatori, Longevity in untreated congenital growth hormone deficiency due to a homozygous mutation in the GHRH receptor gene. J. Clin. Endocrinol. Metab. 295, 714–721 (2010)

83.

M. Franchini, G. Lippi, F. Manzato, P.P. Vescovi, G. Targher, Hemostatic abnormalities in endocrine and metabolic disorders. Eur. J. Endocrinol. 162, 439–451 (2010)PubMed

84.

F. Tanriverdi, A. Gul, I. Gul, N.K. Eryol, K. Unluhizarci, F. Kelestimur, Massive cardiac thrombosis in a patient with Sheehan’s syndrome. Endocr. J. 52, 709–714 (2005)PubMed

85.

L.S. Savendahl, K. Grankvist, K.G. Engstrom, Growth hormone deficiency impairs blood clotting and reduces factor VII coagulant activity in rat. Thromb. Haemost. 73, 626–629 (1995)PubMed

86.

P. Bubber, K.P. Singh, S. Arora, D.D. Bansal, Effect of growth hormone on fibrinolytic system in rat. Indian J. Exp. Biol. 36, 514–516 (1998)PubMed

87.

A. Hamsten, U. de Faire, G. Walldius, G. Dahlen, A. Szamosi, C. Landou, M. Blomback, B. Wiman, Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction. Lancet 2, 3–9 (1987)PubMed

88.

W.B. Kannel, New perspectives on cardiovascular risk factors. Am. Heart J. 114, 213–219 (1987)PubMed

89.

F.B. Smith, A.J. Lee, F.G. Fowkes, J.F. Price, A. Rumley, G.D. Lowe, Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler. Thromb. Vasc. Biol. 17, 3321–3325 (1997)PubMed

90.

J.K. Devin, L.S. Blevins Jr, D.K. Verity, Q. Chen, J.R. Bloodworth Jr, J. Covington, D.E. Vaughan, Markedly impaired fibrinolytic balance contributes to cardiovascular risk in adults with growth hormone deficiency. J. Clin. Endocrinol. Metab. 92, 3633–3639 (2007)PubMed

91.

J.O. Johansson, K. Landin, L. Tengborn, T. Rosen, B.A. Bengtsson, High fibrinogen and plasminogen activator inhibitor activity in growth hormone-deficient adults. Arterioscler. Thromb. 14, 434–437 (1994)PubMed

92.

J. Kvasnicka, J. Marek, T. Kvasnicka, V. Weiss, M. Markova, J. Stepan, A. Umlaufova, Increase of adhesion molecules, fibrinogen, type-1 plasminogen activator inhibitor and orosomucoid in growth hormone (GH) deficient adults and their modulation by recombinant human GH replacement. Clin. Endocrinol. (Oxf.) 52, 543–548 (2000)

93.

M. Margaglione, G. Cappucci, M. d’Addedda, D. Colaizzo, N. Giuliani, G. Vecchione, G. Mascolo, E. Grandone, G. Di Minno, PAI-1 plasma levels in a general population without clinical evidence of atherosclerosis: relation to environmental and genetic determinants. Arterioscler. Thromb. Vasc. Biol. 18, 562–567 (1998)PubMed

94.

M.N. Di Minno, S. Pezzullo, V. Palmieri, C. Di Somma, R. Lupoli, D. Valle, G. Lombardi, G. Di Minno, Protein C and protein S changes in GH-deficient adults on r-HGH replacement therapy: correlations with PAI-1 and t-PA plasma levels. Thromb. Res. 126, e434–e438 (2010)PubMed

95.

J.O. Johansson, K. Landin, G. Johannsson, L. Tengborn, B.A. Bengtsson, Long-term treatment with growth hormone decreases plasminogen activator inhibitor-1 and tissue plasminogen activator in growth hormone-deficient adults. Thromb. Haemost. 76, 422–428 (1996)PubMed

96.

I. Cakir, F. Tanriverdi, Z. Karaca, L. Kaynar, B. Eser, K. Unluhizarci, F. Kelestimur, Evaluation of coagulation and fibrinolytic parameters in adult onset GH deficiency and the effects of GH replacement therapy: a placebo controlled study. Growth Horm. IGF Res. 22, 17–21 (2012)PubMed

97.

D. Miljic, P. Miljic, M. Doknic, S. Pekic, M. Djurovic, M. Colovic, V. Popovic, Changes in prothrombin and activated partial thromboplastin time during replacement therapy with human recombinant growth hormone in growth hormone deficient adults. Hormones (Athens) 5, 187–191 (2006)

98.

T.A. Elhadd, T.A. Abdu, J. Oxtoby, G. Kennedy, M. McLaren, R. Neary, J.J. Belch, R.N. Clayton, Biochemical and biophysical markers of endothelial dysfunction in adults with hypopituitarism and severe GH deficiency. J. Clin. Endocrinol. Metab. 86, 4223–4232 (2001)PubMed

99.

J.M. Gomez, M. Sahun, R. Vila, P. Domenech, P. Catalina, J. Soler, L. Badimon, Peripheral fibrinolytic markers, soluble adhesion molecules, inflammatory cytokines and endothelial function in hypopituitary adults with growth hormone deficiency. Clin. Endocrinol. (Oxf.) 64, 632–639 (2006)

100.

J.M. Gomez, M. Sahun, R. Vila, P. Domenech, P. Catalina, J. Soler, L. Badimon, Elevation of E-selectin concentrations may correlate with potential endothelial dysfunction in individuals with hypopituitarism during therapy with growth hormone. Curr. Neurovasc. Res. 4, 55–62 (2007)PubMed

101.

J.C. Smith, H.A. Lane, J. Lewis, S. Dann, J. Goodfellow, P. Collins, L.M. Evans, M.F. Scanlon, J.S. Davies, Endothelial function and coagulant factors in growth hormone-treated hypopituitary adults receiving desmopressin. J. Clin. Endocrinol. Metab. 88, 2152–2156 (2003)PubMed

102.

S. Bergamaschi, C. Giavoli, E. Ferrante, A. Lania, R. Rusconi, A. Spada, P. Beck-Peccoz, Growth hormone replacement therapy in growth hormone deficient children and adults: effects on hemochrome. J. Endocrinol. Invest. 29, 399–404 (2006)PubMed

Titel: Unusual effects of GH deficiency in adults: a review about the effects of GH on skin, sleep, and coagulation
verfasst von: F. Tanriverdi
Z. Karaca
K. Unluhizarci
F. Kelestimur
Publikationsdatum: 01.12.2014
Verlag: Springer US
Erschienen in: Endocrine / Ausgabe 3/2014
Print ISSN: 1355-008X
Elektronische ISSN: 1559-0100
DOI: https://doi.org/10.1007/s12020-014-0276-0

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 3/2014

Ipilimumab, not just another anti-cancer therapy: hypophysitis as side effect illustrated by four case-reports

Carotid intima-media thickness is not associated with vitamin D and PTH levels in patients admitted to an Internal Medicine Department

Ultrasonography, FNA, mutations, hormones and thyroid nodule obsession in the twenty-first century: a cytopathologist’s plea for reason in the age of thyroid storm

Perioperative androstenedione kinetics in women undergoing laparoscopic ovarian drilling: a prospective study

Meta-analysis of the association of ADIPOQ G276T polymorphism with insulin resistance and blood glucose